Persistent recruitment delays, high dropout rates, and missed timelines continue to slow global clinical trials, while data show that sub-Saharan Africa offers a largely untapped opportunity with ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
The global clinical trials market size was US$ 39,710.5 million in 2021. The global clinical trials market size is forecast to reach US$ 59570.5 million by 2030, growing at a compound annual growth ...
Correspondence to Dr Thomas Bandholm, Dept of Clinical Research, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre DK-2650, Denmark; thomas.quaade.bandholm{at}regionh.dk The REPORT guide ...
Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data, in 2020 75% of trial participants were ...
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...
Funding for clinical trials comes from a wide variety of sources, including government, private investors, charities, universities, and other research institutions, though the vast majority generally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback